Prevention and management of TURP-related hemorrhage.

Nat Rev Urol 2011 Aug 16;8(9):504-14. Epub 2011 Aug 16.

University of Melbourne, Department of Surgery, Ludwig Institute for Cancer Research, Austin Hospital, Studley Road, Heidelberg, Melbourne, Vic 3084, Australia.

Transurethral resection of the prostate (TURP) is the most common surgical treatment for benign prostatic hyperplasia (BPH) worldwide, but despite its minimally invasive nature, perioperative bleeding remains a common morbidity. Anticoagulant and antiplatelet medications are increasingly common in this patient population and further contribute to the risk of bleeding and extended hospital stay. Preoperative cessation of anticoagulant and antiplatelet drugs is recommended but requires risk assessment of thrombotic complications. Pharmacologic maneuvers to reduce hemorrhage include perioperative administration of 5α-reductase inhibitors. Technical considerations include the use of hemostatic energy sources such as laser and bipolar technologies. Ultimately, no surgical technique is devoid of bleeding risks, and urologists should be aware of how best to prevent and treat TURP-related hemorrhage.

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2011.106DOI Listing
August 2011
24 Reads
5 Citations
4.840 Impact Factor

Publication Analysis

Top Keywords

anticoagulant antiplatelet
8
turp-related hemorrhage
8
extended hospital
4
bleeding extended
4
bipolar technologies
4
risk bleeding
4
laser bipolar
4
hospital stay
4
sources laser
4
stay preoperative
4
contribute risk
4
preoperative cessation
4
patient population
4
medications increasingly
4
antiplatelet medications
4
5α-reductase inhibitors
4
morbidity anticoagulant
4
increasingly common
4
ultimately surgical
4
cessation anticoagulant
4

Similar Publications